Top

Clinical and Translational Oncology

Published in:

Open Access 01-12-2019 | Metastasis | Research Article

Metastatic pattern and prognosis of gastrointestinal stromal tumor (GIST): a SEER-based analysis

Authors: D. Y. Yang, X. Wang, W. J. Yuan, Z. H. Chen

Published in: Clinical and Translational Oncology | Issue 12/2019

Abstract

Purpose

This SEER-based study aimed to explore and analyze the relationship of metastasis of liver, lung and bone of GIST patients and their prognosis.

Methods

The data of GIST patients were from Surveillance, Epidemiology, and End Results (SEER) database from 2010 to 2015 and all the statistical analyses were conducted by statistical software package SPSS (Version 22.0).

Results

A total of 4224 GIST patients were identified, of which 388 (9.19%) patients with liver metastasis, 20 (0.47%) patients with bone metastasis and 32 (0.76%) patients with lung metastasis. There was no significant difference of risk of bone or lung metastasis between patients with and without liver metastasis (P = 0.935). The median overall survival of patients with liver, bone, or lung metastasis was, respectively, 49 months, 18 months, and 20 months, which were all shorter than that of patients without metastasis. The overall survival of patients with both liver and bone metastasis and those with metastasis of all three sites was not significantly different from that of patients with only liver metastasis. The multivariate analysis showed age of less than 65 years, female patients, married status and receiving surgery were all the beneficial factors for prognosis of GIST patients with liver metastasis.

Conclusions

Patients with metastasis had a poorer prognosis than those without. Liver metastasis might have no relationship with bone or lung metastasis and liver might play a more dominant role than the other two sites in the prognosis of GIST patients with metastasis. So, more attention should be paid to liver status in diagnosis and treatment of GIST patients.

Acar T, Efe D, Okus A, Ocal I, Harman M. A rare solid tumor of the retroperitoneum with venous extension and lung metastasis: extra-gastrointestinal stromal tumo. Turk J Gastroenterol Off J Turk Soc Gastroenterol. 2015;26:358–9. https://doi.org/10.5152/tjg.2015.0149.CrossRef

Aizer AA, et al. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30:3071–6. https://doi.org/10.1200/jco.2012.42.8466.CrossRef

Aktan M, Koc M, Yavuz BB, Kanyilmaz G. Two cases of gastrointestinal stromal tumor of the small intestine with liver and bone metastasis. Ann Transl Med. 2015;3:259. https://doi.org/10.3978/j.issn.2305-5839.2015.09.46.CrossRefPubMedPubMedCentral

Bauer S, et al. Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib: analysis of prognostic factors (EORTC-STBSG collaborative study). Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2014;40:412–9. https://doi.org/10.1016/j.ejso.2013.12.020.CrossRef

Breccia M, et al. Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival. Leuk Res. 2014;38:1173–6. https://doi.org/10.1016/j.leukres.2014.06.020.CrossRefPubMed

Burkill GJ, Badran M, Al-Muderis O, Meirion Thomas J, Judson IR, Fisher C, Moskovic EC. Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. Radiology. 2003;226:527–32. https://doi.org/10.1148/radiol.2262011880.CrossRefPubMed

Chen M, Wang X, Wei R, Wang Z. The influence of marital status on the survival of patients with operable gastrointestinal stromal tumor: A SEER-based study. Int J Health Plan Manag. 2018. https://doi.org/10.1002/hpm.2661.CrossRef

DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231:51–8.CrossRef

DeMatteo RP, Shah A, Fong Y, Jarnagin WR, Blumgart LH, Brennan MF. Results of hepatic resection for sarcoma metastatic to liver. Ann Surg. 2001;234:540–7 (discussion 547–548).CrossRef

10.

Demetri GD, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Cancer Netw JNCCN. 2010;2(8 Suppl):S1–41 (quiz S42–S44).

11.

Farag S, et al. Elderly patients with gastrointestinal stromal tumour (GIST) receive less treatment irrespective of performance score or comorbidity - A retrospective multicentre study in a large cohort of GIST patients. Eur J Cancer (Oxford, England: 1990). 2017;86:318–25. https://doi.org/10.1016/j.ejca.2017.09.017.CrossRef

12.

Gaitanidis A, Alevizakos M, Tsaroucha A, Simopoulos C, Pitiakoudis M. Incidence and predictors of synchronous liver metastases in patients with gastrointestinal stromal tumors (GISTs). Am J Surg. 2018;216:492–7. https://doi.org/10.1016/j.amjsurg.2018.04.011.CrossRefPubMed

13.

Ghanem N, et al. Computed tomography in gastrointestinal stromal tumors. Eur Radiol. 2003;13:1669–78. https://doi.org/10.1007/s00330-002-1803-6.CrossRefPubMed

14.

Goldzweig G, Andritsch E, Hubert A, Brenner B, Walach N, Perry S, Baider L. Psychological distress among male patients and male spouses: what do oncologists need to know? Annals of oncology: official journal of the European Society for Medical Oncology. 2010;21:877–83. https://doi.org/10.1093/annonc/mdp398.CrossRef

15.

Gomez SL, et al. Effects of marital status and economic resources on survival after cancer: a population-based study. Cancer. 2016;122:1618–25. https://doi.org/10.1002/cncr.29885.CrossRefPubMedPubMedCentral

16.

Jati A, Tatli S, Morgan JA, Glickman JN, Demetri GD, Van den Abbele A, Silverman SG. Imaging features of bone metastases in patients with gastrointestinal stromal tumors. Diagn Interv Radiol (Ankara, Turkey). 2012;18:391–6. https://doi.org/10.4261/1305-3825.dir.5179-11.1.CrossRef

17.

Jiang Z, Zhang J, Li Z, Liu Y, Wang D, Han G. A meta-analysis of prognostic value of KIT mutation status in gastrointestinal stromal tumors. OncoTargets Ther. 2016;9:3387–98. https://doi.org/10.2147/OTT.S101858.CrossRef

18.

Joensuu H, Hohenberger P, Corless CL. Gastrointestinal stromal tumour. Lancet (London, England). 2013;382:973–83. https://doi.org/10.1016/s0140-6736(13)60106-3.CrossRef

19.

Jung SH, Suh KS, Kang DY, Kang DW, Kim YB, Kim ES. Expression of DOG1, PDGFRA, and p16 in gastrointestinal stromal tumors. Gut Liver. 2011;5:171–80. https://doi.org/10.5009/gnl.2011.5.2.171.CrossRefPubMedPubMedCentral

20.

Kalkmann J, et al. Consensus report on the radiological management of patients with gastrointestinal stromal tumours (GIST): recommendations of the German GIST imaging working group. Cancer Imag Off Pub Int Cancer Imag Soc. 2012;12:126–35. https://doi.org/10.1102/1470-7330.2012.0013.CrossRef

21.

Karakousis GC, Singer S, Zheng J, Gonen M, Coit D, DeMatteo RP, Strong VE. Laparoscopic versus open gastric resections for primary gastrointestinal stromal tumors (GISTs): a size-matched comparison. Ann Surg Oncol. 2011;18:1599–605. https://doi.org/10.1245/s10434-010-1517-y.CrossRefPubMedPubMedCentral

22.

Katz SC, DeMatteo RP. Gastrointestinal stromal tumors and leiomyosarcomas. J Surg Oncol. 2008;97:350–9. https://doi.org/10.1002/jso.20970.CrossRefPubMed

23.

Lamba G, Gupta R, Lee B, Ambrale S, Liu D. Current management and prognostic features for gastrointestinal stromal tumor (GIST) Exp. Hematol Oncol. 2012;1:14. https://doi.org/10.1186/2162-3619-1-14.CrossRef

24.

Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23:70–83.CrossRef

25.

Miettinen M, Lasota J. Gastrointestinal stromal tumors. Gastroenterol Clin North Am. 2013;42:399–415. https://doi.org/10.1016/j.gtc.2013.01.001.CrossRefPubMedPubMedCentral

26.

Nilsson B, et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era–a population-based study in western Sweden. Cancer. 2005;103:821–9. https://doi.org/10.1002/cncr.20862.CrossRefPubMed

27.

Osborne C, Ostir GV, Du X, Peek MK, Goodwin JS. The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer. Breast Cancer Res Treat. 2005;93:41–7. https://doi.org/10.1007/s10549-005-3702-4.CrossRefPubMed

28.

Shima Y, et al. Aggressive surgery for liver metastases from gastrointestinal stromal tumors. J Hepato Biliary Pancreat Surg. 2003;10:77–80. https://doi.org/10.1007/s10534-002-0813-9.CrossRef

29.

Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddell RH. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol. 1999;23:377–89.CrossRef

30.

Song W, Tian C. The effect of marital status on survival of patients with gastrointestinal stromal tumors: a SEER database analysis. Gastroenterol Res Pract. 2018;2018:5740823. https://doi.org/10.1155/2018/5740823.CrossRefPubMedPubMedCentral

31.

Soreide K, Sandvik OM, Soreide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39–46. https://doi.org/10.1016/j.canep.2015.10.031.CrossRefPubMed

32.

Suster S. Gastrointestinal stromal tumors. Semin Diag Pathol. 1996;13:297–313.

33.

Tanaka H, Yamazaki N, Watanabe H, Nakade M. Gastrointestinal stromal tumor with metastasis of chest wall and both lungs Kyobu geka. Jpn J Thorac Surg. 2017;70:434–7.

34.

Tran T, Davila JA, El-Serag HB. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol. 2005;100:162–8. https://doi.org/10.1111/j.1572-0241.2005.40709.x.CrossRefPubMed

35.

Vassos N, Agaimy A, Hohenberger W, Croner RS. Extraabdominal lymph node metastasis in gastrointestinal stromal tumors (GIST). J Gastrointest Surg Off J Soc Surg Aliment Tract. 2011;15:1232–6. https://doi.org/10.1007/s11605-011-1464-3.CrossRef

36.

Vassos N, Agaimy A, Hohenberger W, Croner RS. Management of liver metastases of gastrointestinal stromal tumors (GIST). Ann Hepatol. 2015;14:531–9.CrossRef

37.

Waterman BR, Kusnezov N, Dunn JC, Hakim MN. Aggressive gastrointestinal stromal tumor with spinal metastases: a case report. Mil Med. 2015;180:e618–21. https://doi.org/10.7205/milmed-d-14-00552.CrossRefPubMed

Title: Metastatic pattern and prognosis of gastrointestinal stromal tumor (GIST): a SEER-based analysis
Authors: D. Y. Yang
X. Wang
W. J. Yuan
Z. H. Chen
Publication date: 01-12-2019
Publisher: Springer International Publishing
Keywords: Metastasis
Gastrointestinal Stromal Tumor
Bone Metastasis
Published in: Clinical and Translational Oncology / Issue 12/2019
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-019-02094-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 12/2019

Evolution of older patients diagnosed with early breast cancer in Spain between 1998 and 2001 included in El Alamo III project

Anlotinib inhibits synovial sarcoma by targeting GINS1: a novel downstream target oncogene in progression of synovial sarcoma

Perceptions of aging and ageism among Mexican physicians-in-training

Trifluridine/Tipiracil (TAS-102) for refractory metastatic colorectal cancer in clinical practice: a feasible alternative for patients with good performance status

Feasibility of a deep hyperthermia and radiotherapy programme for advanced tumors: first Spanish experience

ECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in Spain

Keynote webinar | Spotlight on antibody–drug conjugates in cancer